Get the most out of Ro­bot­ics Business Review!

This is an article excerpt. Please register to view the entire article.
Learn more about membership benefits or join and become a member today!

MAKO Skirts Adverse Scrutiny
Analyst Outlook
MAKOplasty Comes Under Fire from Some Quarters
By RBR Staff

MAKO Surgical Corp., a medical device company, markets its advanced robotic arm solution and orthopedic implants for orthopedic procedures in the United States and internationally. MAKOplasty, introduced in 2011, is MAKO’s patented RIO Robotic Arm Interactive Orthopedic System, which is designed to support a surgeon’s ability to more accurately align and position a hip implant.

On the positive side, Piper Jaffray rated MAKO a buy, saying MAKO’s “hip launch is about 2 months earlier than anticipated and pricing is expected to be favorable, and the firm believes the Street is underestimating MAKO hip opportunity.” William Blair & Company concurred, reporting that the perceived weakness has made for a buying opportunity. Blair added news of a competitive robotic system from Stryker (SYK) could be introduced within six months, but it expects Stryker will encounter great difficulty competing with MAKO’s broad intellectual and patent holdings with RIO and MAKOplasty.

This is a preview article. Please register to view the entire article.

Get started
Create your membership.
Already a member?

No comments yet. Be the first to post a comment.



View comment guidelines

Remember me

Notify me of follow-up comments?

3D-Printed UAVs Complete Preliminary UK Trials

Parker Hannifin Moves Forward with Indego Exoskeleton

Modular Robotics: A Scrappy Approach to Educational Robots

Factory Robots Get STAMINA Boost

How Honeybee’s Unexpected Meeting with NASA Changed Everything